Fibrinogen, a natural soluble blood protein, is at the heart of Fibriant’s science, technology and products. The conversion of Fibrinogen, by active Thrombin, into the insoluble Fibrin matrix is a pivotal step in hemostasis, tissue repair and host-defense against infections. In nature Fibrinogen and Fibrin appear in different forms, each form with a specific and unique structure-function profile. This variation in form and function provides Fibriant with many opportunities to create new and improved, customized healthcare solutions based on specific variants of human Fibrinogen and Fibrin. Fibriant has developed a recombinant manufacturing platform to produce different variants of human Fibrinogen as well as active human Thrombin.
Company Details
- Address
- Emmy Noetherweg 2c, Leiden,south Holland 2333 Bk,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.fibriant.com/
- Keywords
- Son en Breugel.
- HQ
- Leiden, South Holland
Fibriant Bv Questions
Fibriant Bv's website is https://www.fibriant.com/
Fibriant Bv's LinkedIn profile is https://nl.linkedin.com/company/fibriant-bv
Fibriant Bv's industry is
Biotechnology Research
Fibriant Bv's top competitors are
Leydenjar,
Lava Therapeutics N.v.,
Amphera B.v.,
Globus Medical,
Absano B.v.,
Vectory,
Amylon Therapeutics,
Allero Therapeutics Bv,
Thermo Fisher Scientific,
The Brand Men®.
Fibriant Bv's categories are Biotechnology Research
